{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:55:35Z","timestamp":1760028935885},"reference-count":17,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T00:00:00Z","timestamp":1383177600000},"content-version":"vor","delay-in-days":12875,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[1978,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adequate control of ventricular rate in patients with chronic atrial fibrillation (AF) may not be achieved with digitalis alone. In the present study the additional effect of two different doses (50 mg and 50 + 50 mg) of oral metoprolol, a new selective \u03b2\u2010blocking agent, on ventricular rate in patients with longstanding AF has been studied. A decrease in the mean ventricular rate during rest and during exercise at various work loads was observed after both doses. The effect was more pronounced at the highest work load of 80 W, both after 50 mg (p &lt; 0.002) and after 50 + 50 mg (p &lt; 0.01) of the drug. A high initial heart rate at rest or during exercise was reduced more by the drug than a lower one. Exercise tolerance was reduced in 2 patients. These results suggest that patients with AF in whom satisfactory control of heart rate cannot be achieved with digitalis alone may benefit from addition of individualized metoprolol therapy.<\/jats:p>","DOI":"10.1002\/clc.4960010207","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T12:34:47Z","timestamp":1383222887000},"page":"91-95","source":"Crossref","is-referenced-by-count":8,"title":["Effects of metoprolol on heart rate in patients with digitalis treated chronic atrial fibrillation"],"prefix":"10.1002","volume":"1","author":[{"given":"A.","family":"Khalsa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Edvardsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. B.","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,10,31]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(73)90368-8"},{"key":"e_1_2_1_3_2","article-title":"Animal and human pharmacological studies on metoprolol \u2013a new selective adrenergic \u2014 \u03b21\u2010receptor antagonist","volume":"36","author":"\u00c5blad B.","year":"1975","journal-title":"Acta Pharmacol Toxicol"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","unstructured":"Di BiaseM. BrindiociG. RizzonP.: Effects of prindolol on impulse formation and conduction in man.J Electrocardiol In press (1977).","DOI":"10.1016\/S0022-0736(77)80030-7"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","unstructured":"Di BiaseM. GugliolmiR. ScarciaA. NacciH. RizzonP.: Electrophysiologic properties of intravenous oxprenolol in man.Unpublished data(1977).","DOI":"10.1016\/S0022-0736(77)80069-1"},{"key":"e_1_2_1_6_2","first-page":"61","article-title":"Control of heart rate in atrial fibrillation","volume":"77","author":"Gentzler R.","year":"1974","journal-title":"Pennsylvania Med"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(75)90051-X"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016923909174856"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1975.tb03320.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(65)90028-7"},{"key":"e_1_2_1_11_2","first-page":"287","article-title":"The action of ouabain on the function of the atrioventricular node in rabbits","volume":"169","author":"Noboru T.","year":"1969","journal-title":"J Pharmacol Exp Therap"},{"key":"e_1_2_1_12_2","unstructured":"RizzonP. Di BiaseM. GhiddoA. MastrangeloD. SorgenteL.:Electrophysiologic properties of intravenous metoprolol in man. In press (1977)."},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(74)90283-X"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.39.8.834"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(74)90975-8"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.37.3.231"},{"key":"e_1_2_1_17_2","first-page":"521","article-title":"Electrophysiology and pharmacology of cardiac arrhythmias IX. Cardiac electrophysiologic effects of beta adrenergic receptor stimulation and blockade. Part A","volume":"90","author":"Wit AL","year":"1975","journal-title":"Am Heart J"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(75)90471-8"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960010207","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.4960010207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T23:53:33Z","timestamp":1699314813000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960010207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978,8]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1978,8]]}},"alternative-id":["10.1002\/clc.4960010207"],"URL":"https:\/\/doi.org\/10.1002\/clc.4960010207","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[1978,8]]}}}